October 14, 2017 Uncategorized No Comments

Cardiocity will be presenting the results of the largest opportunistic AF screening trial in the UK at the e-Cardiology/e-Health summit in Berlin in November. Having been shortlisted to present the company are pleased to also be exhibiting the RhythmPad range at this prestigious event in the heart of Europe.

Written by Chris Crockford